SPARC-Europe fully welcomes the Commission’s proposal for a step-by-step approach to introducing new organised cancer testing in the European Union, as early and accurate diagnosis by strengthening evidence-based screening programmes are core elements of cancer care.
SPARC-Europe launches two materials developed to further raise awareness about the challenges related to the delivery of radioligand therapies: a video featuring testimonials of patients who underwent a radioligand therapy treatment and Investment Pathway Guide, which lays down the needs for…
SPARC-Europe launches its very first High-Level Position Paper on Radioligand Cancer Therapies. This publication is a comprehensive overview of the barriers to the accessibility of radioligand therapies and presents recommendations how to overcome them in the context of European policies.
We use cookies on sparc-europe.com (e.g. tracking and analytical cookies), with which an analysis and measurement of user data is possible. Further information can be found in the Data Protection Declaration.
